Using a synthetic membrane to improve healing after tonsil surgery
The Use of Suprathel®250 as a Novel Therapeutical Option for Mucosal Healing in Head and Neck Surgery
This study is testing if a special synthetic membrane can help people heal faster and with less pain after tonsil surgery.
Quick facts
| Phase | Phase1; Phase2 |
|---|---|
| Study type | Interventional |
| Enrollment | 60 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Cairo University Academic / other |
| Locations | 1 site (Stuttgart, Baden-Wurttemberg) |
| Trial ID | NCT06543823 on ClinicalTrials.gov |
What this trial studies
This clinical trial evaluates the effectiveness of SupraTHEL 250, a synthetic biodegradable membrane, for mucosal reconstruction in the head and neck region following tonsillectomy. The membrane is applied to the surgical site to promote faster and less painful healing compared to traditional bare wound healing. The study aims to assess postoperative outcomes, including pain levels and healing rates, to determine if this approach enhances patient quality of life.
Who should consider this trial
Good fit: Ideal candidates for this study are individuals experiencing recurrent episodes of tonsillar infection.
Not a fit: Patients who are children, pregnant or breastfeeding women, or those undergoing chemotherapy or radiotherapy may not benefit from this study.
Why it matters
Potential benefit: If successful, this treatment could significantly reduce postoperative pain and complications for patients undergoing tonsillectomy.
How similar studies have performed: Previous studies have shown positive outcomes using synthetic membranes for wound healing in other contexts, suggesting potential success for this novel application.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * recurrent episodes of tonsillar infection Exclusion Criteria: * children * pregnant/ breastfeeding women * patients undergoing chemo / radiotherapy
Where this trial is running
Stuttgart, Baden-Wurttemberg
- MarienHospital — Stuttgart, Baden-Wurttemberg, Germany (Recruiting)
Study contacts
- Principal investigator: Alaa Emara — Cairo University
- Study coordinator: Alaa Emara
- Email: alaa.emara@polymedics.com
- Phone: +49711719500-182
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.